Effects of tacrolimus on infection of Friend murine leukemia virus to Fv-4 gene heterozygous mice

被引:0
作者
Zhang, FM [1 ]
Yang, BF
Gu, HX
Chen, XB
Zhong, ZH
Cheng, Z
机构
[1] Harbin Med Coll, Dept Microbiol, Harbin 150086, Peoples R China
[2] Harbin Med Coll, Dept Pharmacol, Harbin 150086, Peoples R China
关键词
tacrolimus; murine leukemia virus; transgenic mice;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
AIM: To, investigate the effect of tacrolimus (FK506) on the infection of Friend murine leukemia virus (Friend MuLV) in vivo. METHODS: Three kinds of mice were used including Friend MuLV-sensitive BALB/c mice, Friend MuLV-resistant Fv-4 gene-homozygous mice (Fv-4 mice), and Friend MuLV-resistant Fv-4 gene-heterozygous mice (F1 mice). Tacrolimus was administrated ip to those mice in every 2 d. Those treated mice were inoculated ip with Friend MuLV once on, d 3. The symptoms and viral proliferations in those mice were observed to recognize the Friend MuLV infection. The expression and genotype of Fv-4 gene that resistant against the infection of Friend MuLV were analyzed to confirm the genomic background and related mechanism of the resistance. RESULTS: BALB/c mice and F1 mice, but not Fv-4 mice, appeared obvious early death, spleenomegaly, and viral proliferation after both treatments of viral inoculation and tacrolimus administration, whereas the expression and genotype of Fv-4 gene was not changed in F1 mice and Fv-4 mice with treatment of tacrolimus. Compared to the virus-inoculated control, the Friend MuLV-sensitivity of tacrolimus-treated BALB/c mice and the Friend MuLV-resistance of tacrolimus-treated Fv-4 mice were the same as the controls, but only F1 mice became the symptoms and viral proliferation after both treatments. It suggested the Friend MuLV-resistant F1 mice could be converted to be Friend MuLV-sensitive by treatment of tacrolimus, and this conversion was not depended on the expression and genotype of Fv-4 gene. CONCLUSION: Tacrolimus could not inhibit the infection of Friend MuLV in all mice, furthermore, it could enhance the infection of Friend MuLV in F1 mice. The enhancement may be related to the immunosuppressive effect of tacrolimus.
引用
收藏
页码:208 / 212
页数:5
相关论文
共 16 条
  • [1] Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1
    Briggs, CJ
    Ott, DE
    Coren, LV
    Oroszlan, S
    Tözsér, J
    [J]. ARCHIVES OF VIROLOGY, 1999, 144 (11) : 2151 - 2160
  • [2] NUCLEAR-ASSOCIATION OF A T-CELL TRANSCRIPTION FACTOR BLOCKED BY FK-506 AND CYCLOSPORINE-A
    FLANAGAN, WM
    CORTHESY, B
    BRAM, RJ
    CRABTREE, GR
    [J]. NATURE, 1991, 352 (6338) : 803 - 807
  • [3] Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBj
    Hodge, S
    de Rosayro, J
    Glenn, A
    Ojukwu, IC
    Dewhurst, S
    McClure, HM
    Bischofberger, N
    Anderson, DC
    Klumpp, SA
    Novembre, FJ
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (10) : 8630 - 8639
  • [4] IKETA H, 1985, J VIROL, V55, P768
  • [5] Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice
    Ito, E
    Tanaka, Y
    [J]. MYCOPATHOLOGIA, 1997, 138 (02) : 57 - 64
  • [6] Kageyama S, 1997, ACTA VIROL, V41, P215
  • [7] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS AND GROWTH OF INFECTED T-CELLS BY THE IMMUNOSUPPRESSIVE DRUGS CYCLOSPORINE-A AND FK-506
    KARPAS, A
    LOWDELL, M
    JACOBSON, SK
    HILL, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) : 8351 - 8355
  • [8] Lai JH, 2002, ACTA PHARMACOL SIN, V23, P1093
  • [9] TRANSGENIC FV-4 MICE RESISTANT TO FRIEND-VIRUS
    LIMJOCO, TI
    DICKIE, P
    IKEDA, H
    SILVER, J
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (07) : 4163 - 4168
  • [10] CALCINEURIN IS A COMMON TARGET OF CYCLOPHILIN-CYCLOSPORINE-A AND FKBP-FK506 COMPLEXES
    LIU, J
    FARMER, JD
    LANE, WS
    FRIEDMAN, J
    WEISSMAN, I
    SCHREIBER, SL
    [J]. CELL, 1991, 66 (04) : 807 - 815